<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR20.html">Part 20
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 20.111  Data and information submitted voluntarily to the
                            </h3>
                            <p class="depth0"><em>(a)</em> The provisions of this section shall apply only to data and  information submitted voluntarily to the Food and Drug Administration,  whether in the course of a factory inspection or at any other time, and  not as a part of any petition, application, master file, or other  required submission or request for action. Data and information that may  be required to be submitted to the Food and Drug Administration but that  are submitted voluntarily instead are not subject to the provisions of  this section and will be handled as if they had been required to be  submitted.</p><p class="depth0"><em>(b)</em> A determination that data or information submitted voluntarily  will be held in confidence and will not be available for public  disclosure shall be made only in the form of a regulation published or  cross-referenced in this part.</p><p class="depth0"><em>(c)</em> The following data and information submitted voluntarily to the  Food and Drug Administration are available for public disclosure unless  extraordinary circumstances are shown:</p><p class="depth0"><em>(1)</em> All safety, effectiveness, and functionality data and  information for a marketed ingredient or product, except as provided in  Sec. 330.10(a)(2) of this chapter for OTC drugs.</p><p class="depth0"><em>(2)</em> A protocol for a test or study, unless it is shown to fall  within the exemption established in Sec. 20.61 for trade secrets and  confidential commercial or financial information.</p><p class="depth0"><em>(3)</em> Adverse reaction reports, product experience reports, consumer  complaints, and other similar data and information shall be disclosed as  follows:</p><p class="depth0"><em>(i)</em> If submitted by a consumer or user of the product, the record is  available for public disclosure after deletion of names and other  information that would identify the person submitting the information.</p><p class="depth0"><em>(ii)</em> If submitted by the manufacturer of the product, the record is  available for public disclosure after deletion of:</p><p class="depth0"><em>(a)</em> Names and any information that would identify the person using  the product.</p><p class="depth0"><em>(b)</em> Names and any information that would identify any third party  involved with the report, such as a physician or hospital or other  institution.</p><p class="depth0"><em>(c)</em> Names and any other information that would identify the  manufacturer or the brand designation of the product, but not the type  of product or its ingredients.</p><p class="depth0"><em>(iii)</em> If submitted by a third party, such as a physician or hospital  or other institution, the record is available for public disclosure  after deletion of:</p><p class="depth0"><em>(a)</em> Names and any information that would identify the person using  the product.</p><p class="depth0"><em>(b)</em> Names and any information that would identify any third party  involved with the report, such as a physician or hospital or other  institution.</p><p class="depth0"><em>(iv)</em> If obtained through a Food and Drug Administration  investigation, the record shall have the same status as the initial  report which led to the investigation, i.e., it shall be disclosed in  accordance with paragraph (c)(3)(i) through (iii) of this section.</p><p class="depth0"><em>(v)</em> Any compilation of data, information, and reports prepared in a  way that does not reveal data or information which is not available for  public disclosure under this section is available for public disclosure.</p><p class="depth0"><em>(vi)</em> If a person requests a copy of any such record relating to a  specific individual or a specific incident, such request will be denied  unless accompanied by the written consent to such disclosure of the  person who submitted the report to the Food and Drug Administration and  the individual who is the subject of the report. The record will be  disclosed to the individual who is the subject of the report upon  request.</p><p class="depth0"><em>(4)</em> A list of all ingredients contained in a food or cosmetic,  whether or not it is in descending order of predominance, or a list of  all active ingredients and any inactive ingredients previously disclosed  to the public as defined in Sec. 20.81 contained in a drug, or a list  of all ingredients or components in a device.</p><p class="depth0"><em>(5)</em> An assay method or other analytical method, unless it serves no  regulatory or compliance purpose and is shown to fall within the  exemption established in Sec. 20.61.</p><p class="depth0"><em>(d)</em> The following data and information submitted voluntarily to the  Food   and Drug Administration are not available for public disclosure unless  they have been previously disclosed to the public as defined in Sec.  20.81 or they relate to a product or ingredient that has been abandoned  and they no longer represent a trade secret or confidential commercial  or financial information as defined in Sec. 20.61:</p><p class="depth0"><em>(1)</em> All safety, effectiveness, and functionality data and  information for a developmental ingredient or product that has not  previously been disclosed to the public as defined in Sec. 20.81.</p><p class="depth0"><em>(2)</em> Manufacturing methods or processes, including quality control  procedures.</p><p class="depth0"><em>(3)</em> Production, sales, distribution, and similar data and  information, except that any compilation of such data and information  aggregated and prepared in a way that does not reveal data or  information which is not available for public disclosure under this  provision is available for public disclosure.</p><p class="depth0"><em>(4)</em> Quantitative or semiquantitative formulas.</p><p class="depth0"><em>(e)</em> For purposes of this regulation, safety, effectiveness, and  functionality data include all studies and tests of an ingredient or a  product on animals and humans and all studies and tests on the  ingredient or product for identity, stability, purity, potency,  bioavailability, performance, and usefulness.  [42 FR 15616, Mar. 22, 1977, as amended at 68 FR 25287, May 12, 2003]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
